Conference Coverage: EHA 2023 – Focus on Myelofibrosis (MF)
MF specific discussions on therapeutic advances and their application in clinical decision-making
Faculty Members
Abdulraheem Yacoub, MD
University of Kansas, Lawrence, KS, USA
Kristen Pettit, MD
University of Michigan, Ann Arbor, MI, USA
Ellen K. Ritchie, MD
Weill Cornell Medicine, New York, NY, USA
Gabriela Hobbs, MD
Massachusetts General Hospital, Boston, MA, USA
REPORT TOPICS
- Risk-Adapted Therapy in MF
- JAK Inhibitor-Refractory MF
- Advances in JAK Inhibitors Monotherapy and Combinations
- Beyond JAK Inhibitors
